The quaternization of [14C]pyridine by metabolic N-methylation in vivo has been investigated in eight species by determination of the urinary excretion product, N-methylpyridinium. 2. All eight species N-methylated pyridine, but the extent to which this occurred was species-dependent; methylation was extensive (20-40% dose) in the cat, guinea-pig, gerbil, rabbit and hamster,but was low (5-12% dose) in rat, mouse and two human volunteers. The low N-methylation in the rat was not enhanced by DL-methionine supplementation. 3. In the rat and guinea-pig, the pattern of N-methylation was similar when the [14C]pyridine was given by the oral and intraperitoneal routes. In both species the reaction was dose-dependent. 4. N-Methylpyridinium excretion was found to be a valid parameter of the N-methylation of pyridine in vivo, since rats and guinea-pigs eliminated this compound in the urine unchanged following its intraperitoneal administration. 5. The pharmacological and toxicological implications of the biological quaternization of azaheterocycles are discussed.
No takes yet. Share an insight, caveat, or question.
D’Souza et al. (1980) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: